Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Event”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Not applicableStudy completedNCT05974345
What this trial is testing

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 204,691
Large-scale testing (Phase 3)Active Not RecruitingNCT05030428
What this trial is testing

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 17,004
Large-scale testing (Phase 3)Not Yet RecruitingNCT07242599
What this trial is testing

Ongericimab Injection Reducing Recurrence of Ischemic Stroke

Who this might be right for
Ischemic Cerebral Infarction
Beijing Tiantan Hospital 4,810
Large-scale testing (Phase 3)Looking for participantsNCT07241390
What this trial is testing

Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

Who this might be right for
Atherosclerosis Cardiovascular DiseaseChronic Kidney Disease
Eli Lilly and Company 7,140
Large-scale testing (Phase 3)Looking for participantsNCT07613294
What this trial is testing

See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Who this might be right for
AtherosclerosisCardiovascular DiseasesLipoprotein(a)
Eli Lilly and Company 252
Large-scale testing (Phase 3)Looking for participantsNCT07524335
What this trial is testing

Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

Who this might be right for
Coronary Artery DiseaseSubclinical Atherosclerotic Cardiovascular Disease
Montreal Heart Institute 48
Post-approval studies (Phase 4)UnknownNCT05976893
What this trial is testing

Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer

Who this might be right for
ASCVDAtherosclerotic Cardiovascular DiseaseProprotein Convertase Subtilisin/Kexin Type 9 Inhibitor+1 more
Xiang Xie 620
Post-approval studies (Phase 4)Looking for participantsNCT07796217
What this trial is testing

Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy

Who this might be right for
Cardiac EventCoronary Artery DiseasePeripheral Artery Disease+1 more
Seoul National University Bundang Hospital 2,758
Not applicableUnknownNCT06406998
What this trial is testing

Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD

Who this might be right for
Cardiovascular DiseasesAtherosclerosisPregnancy Complications+2 more
Samsung Medical Center 5,461,222
Not applicableStudy completedNCT02959099
What this trial is testing

Incident COronary EveNts Identified by Computed Tomography

Who this might be right for
Atherosclerosis
Weill Medical College of Cornell University 476
Large-scale testing (Phase 3)Looking for participantsNCT07293260
What this trial is testing

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

Who this might be right for
Cardiovascular Disease
Amgen 406
Not applicableEnrolling By InvitationNCT07625488
What this trial is testing

Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)

Who this might be right for
Coronary Artery DiseaseAtherosclerosis
Radboud University Medical Center 250
Large-scale testing (Phase 3)Active Not RecruitingNCT06383390
What this trial is testing

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)
Eli Lilly and Company 10,000
Not applicableStudy completedNCT06935279
What this trial is testing

Bacteria in Atherosclerotic Plaques and Adverse Events

Who this might be right for
Carotid Artery StenosisCerebral InfarctionDiabetes+7 more
Tang-Du Hospital 200
Not applicableUnknownNCT02017756
What this trial is testing

Chinese Atherosclerosis Risk Evaluation- Phase II

Who this might be right for
Ischemic StrokeTransient Ischemic AttackCarotid Atherosclerotic Disease
Tsinghua University 1,000
Not applicableUnknownNCT01882114
What this trial is testing

Atherosclerosis in Atrial Fibrillation

Who this might be right for
Atrial FibrillationMetabolic SyndromeOxidative Stress+2 more
University of Roma La Sapienza 3,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590012
What this trial is testing

SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY

Who this might be right for
AtherosclerosisAtheroscleroses, CoronaryCarotid Atherosclerosis
Institute for Atherosclerosis Research, Russia 1,228
Not applicableActive Not RecruitingNCT07832175
What this trial is testing

AI-CCTA for Predicting Cardiovascular Events in CAD

Who this might be right for
Coronary Artery DiseaseAtherosclerotic Cardiovascular Disease
Nanjing First Hospital, Nanjing Medical University 3,000